Category: Global lab testing and insights

Scope of Alzheimer’s Disease Testing

BeaconLBS June 29, 2021

Alzheimer’s disease (AD) was first described in 1907 by Aloysius Alzheimer who was caring for patients at a state psychiatric hospital in Frankfurt, Germany. He depicted a patient as having severely impaired memory, trouble with reading and writing, the inability to understand basic questions, and the loss of recognition of everyday objects.

Read More

Traumatic Brain Injury Testing

BeaconLBS April 6, 2021

The direct and indirect costs of medical diagnosis and treatment, in combination with lost productivity for mild TBI, may be greater than $60 billion annually.

Read More

Thyroid Disease Testing

Thyroid Disease Testing
BeaconLBS February 4, 2021

Thyroid disease is estimated to affect 20 million people in the United States, with up to 60% being undiagnosed.

Read More

COVID-19 Testing

COVID-19 Testing
BeaconLBS December 9, 2020

As the virus can be transmitted prior to the onset of symptoms, it is best to diagnose patients with COVID-19 prior to symptomatic onset to reduce the spread of the virus.

Read More

Cardiac Biomarkers

Cardiac Biomarkers
BeaconLBS October 15, 2020

It is vital, as new discoveries are made in cardiac biomarkers, that well-designed studies that provide clinical validity and utility are published.

Read More